Effects of the mycotoxin fumonisin B1 on cell death in human kidney cells and human lung fibroblasts in primary culture

Journal of Applied Toxicology

Volumn 29, Issue 2, 2009, Pages 174-182

  Schwerdt, G ^a   Konigs M ^b   Holzinger, H ^c   Humpf, H U ^b   Gekle, M ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Apoptosis; Collagen homeostasis; Kidney; Lung; Mycotoxin; Necrosis

Indexed keywords

CASPASE 3; COLLAGEN; COLLAGEN TYPE 3; COLLAGEN TYPE 4; FIBRONECTIN; FUMONISIN B1; LACTATE DEHYDROGENASE;

APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; HOMEOSTASIS; HUMAN; HUMAN CELL; KIDNEY CELL; LIQUID CHROMATOGRAPHY; LUNG FIBROBLAST; MASS SPECTROMETRY; METABOLISM; NECROSIS; PRIORITY JOURNAL; PROTEIN SECRETION;

APOPTOSIS; CASPASE 3; CELL DEATH; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE III; COLLAGEN TYPE IV; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FIBROBLASTS; FIBRONECTINS; FUMONISINS; HUMANS; KIDNEY; L-LACTATE DEHYDROGENASE; LUNG; MYCOTOXINS; TIME FACTORS;

GIBBERELLA MONILIFORMIS;

EID: 62849092993     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1398     Document Type: Article

References (51)

1. Bergmeyer HU, Bernt E. 1974. Laktat-Dehydrogenase. In Methoden der enzymatischen Analyse, Bergmeyer HU (ed.). Verlag Chemie: Weinheim; 607-612.
2. Bouhet S, Oswald IP. 2007. The intestine as a possible target for fumonisin toxicity. Mol. Nutr. Food Res. 51: 925-931.
3. Chu FS, Li GY. 1994. Simultaneous occurrence of fumonisin B1 and other mycotoxins in moldy corn collected from the People's Republic of China in regions with high incidences of esophageal cancer. Appl. Environ. Microbiol. 60: 847-852.
4. Ciacci-Zanella JR, Jones C. 1999. Fumonisin B1, a mycotoxin contaminant of cereal grains, and inducer of apoptosis via the tumour necrosis factor pathway and caspase activation. Food Chem. Toxicol. 37: 703-712.
5. Del Bianchi M, Oliveira CA, Albuquerque R, Guerra JL, Correa B. 2005. Effects of prolonged oral administration of aflatoxin B1 and fumonisin B1 in broiler chickens. Poult. Sci. 84: 1835-1840.
6. Desai K, Sullards MC, Allegood J, Wang E, Schmelz EM, Hartl M, Humpf HU, Liotta DC, Peng Q, Merrill AH, Jr. 2002. Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis. Biochim. Biophys. Acta 1585: 188-192.
7. Esposito C, Fornoni A, Cornacchia F, Bellotti N, Fasoli G, Foschi A, Mazzucchelli I, Mazzullo T, Semeraro L, Dal Canton A. 2000. Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures. Kidney Int. 58: 123-130.
8. European Commission. 2000. Opinion of the Scientific Committee on Food on Fusarium Toxins, Part 3: Fumonisin B1 (FB1).
9. European Commission. 2003. Updated opinion of the Scientific Committee on Food on Fumonisin B1, B2 and B3.
10. European Commission. 2006. Commission regulation (EC) No. 1881/2006. Official Journal of the European Union.
11. Gelderblom WC, Jaskiewicz K, Marasas WF, Thiel PG, Horak RM, Vleggaar R, Kriek NP. 1988. Fumonisins - novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl. Environ. Microbiol. 54: 1806-1811.
12. Gelderblom WC, Kriek NP, Marasas WF, Thiel PG. 1991. Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis 12: 1247-1251.
13. Gelderblom WC, Abel S, Smuts CM, Marnewick J, Marasas WF, Lemmer ER, Ramljak D. 2001a. Fumonisin-induced hepatocarcinogenesis: mechanisms related to cancer initiation and promotion. Environ. Health Perspect. 109(Suppl. 2): 291-300.
14. Gelderblom WC, Lebepe-Mazur S, Snijman PW, Abel S, Swanevelder S, Kriek NP, Marasas WF. 2001b. Toxicological effects in rats chronically fed low dietary levels of fumonisin B(1). Toxicology 161: 39-51.
15. Harrison LR, Colvin BM, Greene JT, Newman LE, Cole JR Jr. 1990. Pulmonary edema and hydrothorax in swine produced by fumonisin B1, a toxic metabolite of Fusarium moniliforme. J. Vet. Diagn. Invest. 2: 217-221.
16. Haschek WM, Gumprecht LA, Smith G, Tumbleson ME, Constable PD. 2001. Fumonisin toxicosis in swine: an overview of porcine pulmonary edema and current perspectives. Environ. Health Perspect. 109(Suppl 2): 251-257.
17. Hendricks K. 1999. Fumonisins and neural tube defects in South Texas. Epidemiology 10: 198-200.
18. Howard PC, Eppley RM, Stack ME, Warbritton A, Voss KA, Lorentzen RJ, Kovach RM, Bucci TJ. 2001. Fumonisin b1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice. Environ. Health Perspect. 109(Suppl 2): 277-282.
19. Howard PC, Couch LH, Patton RE, Eppley RM, Doerge DR, Churchwell MI, Marques MM, Okerberg CV. 2002. Comparison of the toxicity of several fumonisin derivatives in a 28-day feeding study with female B6C3F(1) mice. Toxicol. Appl. Pharmacol. 185: 153-165.
20. Humpf HU, Voss KA. 2004. Effects of thermal food processing on the chemical structure and toxicity of fumonisin mycotoxins. Mol. Nutr. Food Res. 48: 255-269.
21. International Agency for research on Cancer. 2002. Monographs on the evaluation of carcinogenic risks to humans. Fumonisin B1. Some traditional herbal medicines, some mycotoxins, naphtalene and styrene. 82: 301-366.
22. Javed T, Bunte RM, Dombrink-Kurtzman MA, Richard JL, Bennett GA, Cote LM, Buck WB. 2005. Comparative pathologic changes in broiler chicks on feed amended with Fusarium proliferatum culture material or purified fumonisin B1 and moniliformin. Mycopathologia 159: 553-564.
23. Kellerman TS, Marasas WF, Thiel PG, Gelderblom WC, Cawood M, Coetzer JA. 1990. Leukoencephalomalacia in two horses induced by oral dosing of fumonisin B1. Onderstepoort J. Vet. Res. 57: 269-275.
24. Kim MS, Lee DY, Wang T, Schroeder JJ. 2001. Fumonisin B(1) induces apoptosis in LLC-PK(1) renal epithelial cells via a sphinganine- and calmodulin-dependent pathway. Toxicol. Appl. Pharmacol. 176: 118-126.
25. Lane RD, Federman D, Flora JL, Beck BL. 1986. Computer-assisted determination of protein concentrations from dye-binding and bicinchoninic acid protein assays performed in microtiter plates. J. Immunol. Meth. 92: 261-270.
26. Lemmer ER, de la Motte HP, Omori N, Omori M, Shephard EG, Gelderblom WC, Cruse JP, Barnard RA, Marasas WF, Kirsch RE, Thorgeirsson SS. 1999. Histopathology and gene expression changes in rat liver during feeding of fumonisin B1, a carcinogenic mycotoxin produced by Fusarium moniliforme. Carcinogenesis 20: 817-824.
27. Lim CW, Parker HM, Vesonder RF, Haschek WM. 1996. Intravenous fumonisin B1 induces cell proliferation and apoptosis in the rat. Nat. Toxins. 4: 34-41.
28. Marasas WF. 2001. Discovery and occurrence of the fumonisins: a historical perspective. Environ. Health Perspect. 109(Suppl. 2): 239-243.
29. Marasas WF, Kellerman TS, Gelderblom WC, Coetzer JA, Thiel PG, van der Lugt JJ. 1988. Leukoencephalomalacia in a horse induced by fumonisin B1 isolated from Fusarium moniliforme. Onderstepoort J. Vet. Res. 55: 197-203.
30. Marasas WF, Riley RT, Hendricks KA, Stevens VL, Sadler TW, Gelineau-van Waes J, Missmer SA, Cabrera J, Torres O, Gelderblom WC, Allegood J, Martinez C, Maddox J, Miller JD, Starr L, Sullards MC, Roman AV, Voss KA, Wang E, Merrill AH Jr. 2004. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J. Nutr. 134: 711-716.
31. Merrill AH Jr, Sullards MC, Wang E, Voss KA, Riley RT. 2001. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ. Health Perspect. 109(Suppl. 2): 283-289.
32. Missmer SA, Suarez L, Felkner M, Wang E, Merrill AH Jr, Rothman KJ, Hendricks KA. 2006. Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environ. Health Perspect. 114: 237-241.
33. Ramasamy S, Wang E, Hennig B, Merrill AH, Jr. 1995. Fumonisin B1 alters sphingolipid metabolism and disrupts the barrier function of endothelial cells in culture. Toxicol. Appl. Pharmacol. 133: 343-348.
34. Rheeder JP, Marasas WFO, Thiel PG, Sydenham EW, Shepard GS. 1992. Fusarium moniliforme and fumonisins in corn in relation to human esophageal cancer in transkei. Phytopathology 82: 353-357.
35. Riley RT, Voss KA. 2006. Differential sensitivity of rat kidney and liver to fumonisin toxicity: organ specific differences in toxin accumulation and sphingoid base metabolism. Toxicol. Sci. 92: 335-345.
36. Riley RT, Enongene E, Voss KA, Norred WP, Meredith FI, Sharma RP, Spitsbergen J, Williams DE, Carlson DB, Merrill AH Jr. 2001. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ. Health Perspect. 109(Suppl. 2): 301-308.
37. Sauvant C, Holzinger H, Mildenberger S, Gekle M. 2005. Exposure to nephrotoxic ochratoxin A enhances collagen secretion in human renal proximal tubular cells. Mol. Nutr. Food Res. 49: 31-37.
38. Schmelz EM, Dombrink-Kurtzman MA, Roberts PC, Kozutsumi Y, Kawasaki T, Merrill AH Jr. 1998. Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases. Toxicol. Appl. Pharmacol. 148: 252-260.
39. Schwerdt G, Gordjani N, Freudinger R, Wollny B, Kirchhoff A, Gekle M. 2006. Chloroacetaldehyde and acrolein-induced death of human proximal tubule cells. Pediatr. Neph. 21: 60-67.
40. Schwerdt G, Holzinger H, Sauvant C, Königs M, Humpf HU, Gekle M. 2007. Long-term effects of ochratoxin A on fibrosis and cell death in human proximal tubule or fibroblast cells in primary culture. Toxicology 232: 57-67.
41. Seefelder W, Humpf HU, Schwerdt G, Freudinger R, Gekle M. 2002. Induction of apoptosis in cultured human proximal tubule cells by fumonisins and fumonisin metabolites. Toxicol. Appl. Pharmacol. 192: 146-153.
42. Seiferlein M, Humpf HU, Voss KA, Sullards MC, Allegood JC, Wang E, Merrill AH Jr. 2007. Hydrolyzed fumonisins HFB1 and HFB2 are acylated in vitro and in vivo by ceramide synthase to form cytotoxic N-acyl-metabolites. Mol. Nutr. Food Res. 51: 1120-1130.
43. Sharma RP, Dugyala RR, Voss KA. 1997. Demonstration of in-situ apoptosis in mouse liver and kidney after short-term repeated exposure to fumonisin B1. J. Comp. Pathol. 117: 371-381.
44. Smith ER, Jones PL, Boss JM, Merrill AH, Jr. 1997. Changing J774A.1 cells to new medium perturbs multiple signaling pathways, including the modulation of protein kinase C by endogenous sphingoid bases. J. Biol. Chem. 272: 5640-5646.
45. Tolleson WH, Dooley KL, Sheldon WG, Thurman JD, Bucci TJ, Howard PC. 1996a. The mycotoxin fumonisin induces apoptosis in cultured human cells and in livers and kidneys of rats. Adv. Exp. Med. Biol. 392: 237-250.
46. Tolleson WH, Melchior WB Jr, Morris SM, McGarrity LJ, Domon OE, Muskhelishvili L, James SJ, Howard PC. 1996b. Apoptotic and anti-proliferative effects of fumonisin B1 in human keratinocytes, fibroblasts, esophageal epithelial cells and hepatoma cells. Carcinogenesis 17: 239-249.
47. Vesey DA, Cheung CW, Cuttle L, Endre ZA, Gobe G, Johnson DW. 2002. Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production. Kidney Int. 62: 31-40.
48. Voss KA, Riley RT, Norred WP, Bacon CW, Meredith FI, Howard PC, Plattner RD, Collins TF, Hansen DK, Porter JK. 2001. An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme. Environ. Health Perspect. 109(Suppl 2): 259-266.
49. Wang E, Norred WP, Bacon CW, Riley RT, Merrill AH, Jr. 1991. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266: 14486-14490.
50. World Health Organization. 2000. International Programme on Chemical Safety. Environ Health Criteria 219: 1-150.
51. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP. 1990. High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am. J. Physiol. 259: F704-F714.